End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13,000 KRW | -0.15% |
|
-0.23% | -28.41% |
22/05 | Dong-A ST to Become Second-Largest Shareholder of Idience in KRW25 Billion Deal | MT |
2023 | Il Dong Pharmaceutical Eyes Approval for to Manufacture Japan's COVID-19 Treatment in South Korea | MT |
Chart calendar Ildong Pharmaceutical Co., Ltd.
Upcoming events on Ildong Pharmaceutical Co., Ltd.
Past events on Ildong Pharmaceutical Co., Ltd.
09/05/2024 | Q1 2024 Earnings Release |
08/02/2024 | Q4 2023 Earnings Release |
15/05/2023 | Q1 2023 Earnings Release |
16/03/2023 | Q4 2022 Earnings Release |
13/01/2023 | Roadshow - Day - 2 |
12/01/2023 | Roadshow - Day - 1 |
14/11/2022 | Q3 2022 Earnings Release |
16/08/2022 | Interim 2022 Earnings Release |
16/05/2022 | Q1 2022 Earnings Release |
17/08/2021 | Interim 2021 Earnings Release |
17/05/2021 | Q1 2021 Earnings Release |
18/03/2021 | FY 2020 Earnings Release |
30/03/2020 | FY 2019 Earnings Release |
14/11/2019 | Q3 2019 Earnings Release |
15/05/2019 | Q1 2019 Earnings Release |
20/02/2018 | FY 2017 Earnings Release |
Past dividends on Ildong Pharmaceutical Co., Ltd.
27/12/2018 | Annual 400 KRW |
27/12/2017 | Annual 400 KRW |
28/12/2016 | Annual 300 KRW |
Annual results
Fiscal Period | December | 2019 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Net sales Billions KRW | Released Forecast Spread | 517 532 -2.78% | 636 645 -1.42% | 598 597 0.24% | 626 |
EBITDA Billions KRW | Released Forecast Spread | 25,7 53,8 -52.17% | -43,0 -15,0 -186.54% | -13,4 -17,0 21.13% | 85,0 |
EBIT Billions KRW | Released Forecast Spread | -1,90 26,1 -107.28% | -72,1 -41,0 -75.97% | -40,9 -41,0 0.21% | 59,3 |
Earnings before Tax (EBT) Billions KRW | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -82,0 -96,5 14.98% | 47,5 |
Net income Billions KRW | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -71,5 -93,7 23.71% | 38,8 |
EPS KRW | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -2 469 -3 338 26.03% | 1 382 |
Announcement Date | 14/02/20 | 09/02/23 | 08/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q2 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|
Net sales Billions KRW | Released Forecast Spread | 162 143 13.31% | 149 148 0.99% | 151 151 -0.48% | 154 | 159 | 162 |
EBIT Billions KRW | Released Forecast Spread | -22,0 17,0 -229.59% | 15,1 12,9 16.7% | 14,2 | 14,6 | 15,5 | |
Earnings before Tax (EBT) Billions KRW | Released Forecast Spread | 0,02 -14,5 100.12% | 17,9 12,4 44.65% | 10,7 | 9,10 | 9,80 | |
Net income Billions KRW | Released Forecast Spread | 7,50 -14,7 151.03% | 13,6 11,1 22.69% | 9,10 | 7,80 | 8,30 | |
Announcement Date | 27/07/22 | 08/02/24 | 09/05/24 | - | - | - |
Past sector events for Ildong Pharmaceutical Co., Ltd.
21/06/2024 08:58 pm | DEVA HOLDING: Q1 2024 Earnings Release |
14/06/2024 02:51 am | EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release |
11/06/2024 11:00 am | BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release |
07/06/2024 04:03 pm | SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release |
07/06/2024 02:47 pm | LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release |
30/05/2024 05:38 pm | SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
30/05/2024 04:30 pm | ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release |
30/05/2024 11:54 am | MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release |
29/05/2024 05:30 pm | FDC LIMITED: Q4 2024 Earnings Release |
29/05/2024 02:56 pm | JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- A249420 Stock
- Calendar Ildong Pharmaceutical Co., Ltd.